Finch Therapeutics
Phase 3Finch, an early pioneer in the emerging field of microbiome therapeutics, has established a leading portfolio of innovative microbiome assets with potential applicability to a wide range of product strategies and therapeutic areas.
Founded
2014
Focus
BiologicsMicrobiome
About
Finch, an early pioneer in the emerging field of microbiome therapeutics, has established a leading portfolio of innovative microbiome assets with potential applicability to a wide range of product strategies and therapeutic areas.
Funding History
3Total raised: $153M
Series C$90MPerceptive AdvisorsMar 15, 2021
Series B$53MOMX VenturesJan 15, 2020
Series A$10MSeventure PartnersJun 15, 2017
Company Info
TypePrivate
Founded2014
LocationSomerville, United States
StagePhase 3
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile